文章摘要
房颤患者PCI术后华法林的合理使用与药学监护
Rational use and pharmaceutical care of warfarin in patients with Atrial Fibrillation After PCI
投稿时间：2020-05-16  修订日期：2020-10-03
DOI：
中文关键词: 房颤PCI术后 华法林 药学监护
英文关键词: Atrial Fibrillation After PCI  Warfarin  Pharmacological practice
基金项目:新乡市科技攻关项目(编号:CXGG17039)
作者单位邮编
张惠丽* 新乡市第二人民医院临床药学科 453002
仲宁 新乡市第二人民医院心血管内科 
杨庆蕊 新乡市中心医院临床药学科 
马琳 新乡市第二人民医院检验科 
摘要点击次数: 362
全文下载次数: 0
中文摘要:
      摘 要 目的：探索房颤患者PCI术后华法林的合理使用与药学监护。方法：结合房颤PCI术后最新临床数据特征和华法林防治指南、合理用药专家共识、文献资料以及临床药师工作经验，制定药学监护工作模式。从患者因素、药物因素、药物捡测、相互作用、不良反应监测等方面进行分析。结果与结论：房颤患者术后药物治疗较为棘手，因此及时进行房颤患者风险评估和防治，实施个体化给药治疗，提供实时的药学监护是十分必要的。
英文摘要:
      ABSTRACT OBJECTIVE: To explore the rational use and pharmaceutical care of warfarin in patients with Atrial Fibrillation After PCI. METHODS: according to the latest clinical data of Atrial Fibrillation After PCI, warfarin prevention and treatment guidelines, consensus of rational drug use experts, literature and clinical pharmacists' work experience, the working mode of pharmaceutical care was developed. Analysis was carried out from the aspects of patient factors, drug factors, drug detection, interaction and adverse reaction monitoring. RESULTS and CONCLUSION: the drug treatment of Atrial Fibrillation After PCI is relatively difficult, so it is very necessary to timely carry out risk assessment and prevention for patients with atrial fibrillation, implement individualized drug administration and provide real-time pharmaceutical care.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭